{"id":448,"date":"2023-11-30T16:17:00","date_gmt":"2023-11-30T08:17:00","guid":{"rendered":"http:\/\/en.metabiopharma.com\/?p=448"},"modified":"2024-03-20T16:23:44","modified_gmt":"2024-03-20T08:23:44","slug":"recent_awards_by_meta_pharmaceuticals","status":"publish","type":"post","link":"http:\/\/en.metabiopharma.com\/index.php\/2023\/11\/30\/recent_awards_by_meta_pharmaceuticals\/","title":{"rendered":"Recent Awards by META Pharmaceuticals\ufffc"},"content":{"rendered":"\n<p>Recently, Shenzhen Moyuan Biotechnology Co., Ltd (hereinafter referred to as &#8220;META Pharmaceuticals&#8221;) has won a number of competitions.<\/p>\n\n\n\n<ol type=\"1\"><li><strong>META Pharmaceuticals was honored as &#8220;Excellent Enterprise&#8221; in China Innovation and Entrepreneurship Competition Biomedicine National Competition<\/strong><strong><\/strong><\/li><\/ol>\n\n\n\n<p>On November 23rd, the 12th China Innovation and Entrepreneurship Competition Biomedicine National Competition, jointly organized by the Ministry of Science and Technology (MOST), the Ministry of Finance (MOF), the Ministry of Education (MOE), the Central Internet Information Office (CIIO), and the All-China Federation of Industry and Commerce (ACFIC), commenced in Taizhou. Xu Yi, the head of relevant institutions directly under the Ministry of Science and Technology, Zhang Xinmin, the director of China Biotechnology Development Center (CBDC), Zhu Lifan, the secretary of Taizhou Municipal Party Committee, as well as responsible comrades from relevant departments of CBDC, the Taizhou Development and Reform Commission (DRC), the Taizhou Science and Technology Bureau (TSTB), and the Taizhou Pharmaceutical Hi-Tech Zone Administrative Committee (TPZAC), participated in the opening ceremony.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"828\" height=\"551\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-23.png\" alt=\"\" class=\"wp-image-449\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-23.png 828w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-23-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-23-768x511.png 768w\" sizes=\"(max-width: 828px) 100vw, 828px\" \/><\/figure>\n\n\n\n<p>After the district and city competitions, META Pharmaceuticals\u00a0was selected as a finalist\u00a0in the National Biopharmaceutical Competition\u00a0for its application and development of immunometabolic strategies\u00a0on small molecule drugs\u00a0for various chronic diseases. The company finally won the title of \u201cExcellent Enterprise\u201d\u00a0among the 324 excellent biopharmaceutical enterprises\u00a0in the National Competition. Dr. Ke Xu, co-founder and CEO of META Pharmaceuticals, represented the company\u00a0to give a live defense\u00a0and receive the award on the stage.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"828\" height=\"553\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-24.png\" alt=\"\" class=\"wp-image-450\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-24.png 828w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-24-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-24-768x513.png 768w\" sizes=\"(max-width: 828px) 100vw, 828px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-25.png\" alt=\"\" class=\"wp-image-451\" width=\"479\" height=\"335\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-25.png 831w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-25-300x210.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-25-768x537.png 768w\" sizes=\"(max-width: 479px) 100vw, 479px\" \/><\/figure><\/div>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954-777x1024.jpg\" alt=\"\" class=\"wp-image-452\" width=\"477\" height=\"629\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954-777x1024.jpg 777w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954-228x300.jpg 228w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954-768x1013.jpg 768w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954-1165x1536.jpg 1165w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u5fae\u4fe1\u56fe\u7247_20240320161954.jpg 1268w\" sizes=\"(max-width: 477px) 100vw, 477px\" \/><\/figure><\/div>\n\n\n\n<p><strong>2.META Pharmaceuticals was awarded &#8220;Excellence Award&#8221; in the Grand Final of 2023 Golden Panda Global Innovation and Entrepreneurship Competition<\/strong><strong><\/strong><\/p>\n\n\n\n<p>On November 17, 2023, the Golden Panda Global Innovation &amp; Entrepreneurship Competition Grand Final\u00a0was successfully held\u00a0in the Chengdu Hi-Tech Zone. The event was hosted by the Chengdu Municipal People\u2019s Government\u00a0and organized by the Chengdu Hi-Tech Zone Administrative Committee. The competition drew a total of 2,085 project applications, and after 10 domestic and international field competitions, 46 projects\u00a0advanced to the finals.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"830\" height=\"553\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-26.png\" alt=\"\" class=\"wp-image-453\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-26.png 830w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-26-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-26-768x512.png 768w\" sizes=\"(max-width: 830px) 100vw, 830px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"830\" height=\"553\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-27.png\" alt=\"\" class=\"wp-image-454\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-27.png 830w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-27-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-27-768x512.png 768w\" sizes=\"(max-width: 830px) 100vw, 830px\" \/><\/figure>\n\n\n\n<p>After a rigorous selection process, Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals, represented the company\u00a0in winning the Excellence Award\u00a0and the corresponding bonus. The award was received on behalf of the company\u00a0for their research project\u00a0titled \u201cResearch and Development of National Class I Innovative Immunosuppressive Drugs Based on Immuno-metabolism Strategies\u201d. This project stood out\u00a0among many others in the field of cutting-edge biomedical science and technology.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"830\" height=\"553\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-28.png\" alt=\"\" class=\"wp-image-455\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-28.png 830w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-28-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-28-768x512.png 768w\" sizes=\"(max-width: 830px) 100vw, 830px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"830\" height=\"553\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-29.png\" alt=\"\" class=\"wp-image-456\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-29.png 830w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-29-300x200.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-29-768x512.png 768w\" sizes=\"(max-width: 830px) 100vw, 830px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"831\" height=\"587\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-30.png\" alt=\"\" class=\"wp-image-457\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-30.png 831w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-30-300x212.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-30-768x542.png 768w\" sizes=\"(max-width: 831px) 100vw, 831px\" \/><\/figure>\n\n\n\n<p>3.<strong>META Pharmaceuticals Won the Third Prize in China Huaihai High-level Talents Entrepreneurship Competition<\/strong><\/p>\n\n\n\n<p>Recently, the first China Huaihai High-level Talents Entrepreneurship Competition\u00a0and Xuzhou Economic Development Zone High-level Talents Innovation and Entrepreneurship Competition for Biomedical Health\u00a0were successfully held in Shenzhen. More than 30 projects, led by academicians from overseas developed countries, national high-level talents, and teams, applied for the competition. META Pharmaceuticals, among several outstanding enterprises, achieved a top 6 ranking\u00a0in the project, winning the third prize\u00a0and receiving the corresponding bonus reward.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"830\" height=\"438\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-31.png\" alt=\"\" class=\"wp-image-458\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-31.png 830w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-31-300x158.png 300w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/image-31-768x405.png 768w\" sizes=\"(max-width: 830px) 100vw, 830px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" src=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u56fe\u724712-768x1024.png\" alt=\"\" class=\"wp-image-459\" width=\"556\" height=\"741\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u56fe\u724712-768x1024.png 768w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u56fe\u724712-225x300.png 225w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2024\/03\/\u56fe\u724712.png 960w\" sizes=\"(max-width: 556px) 100vw, 556px\" \/><\/figure><\/div>\n\n\n\n<p>The <strong>fact that META Pharmaceuticals<\/strong>\u00a0was able to <strong>enter and win several national competitions<\/strong>\u00a0over the past <strong>2 years<\/strong>\u00a0<strong>reflects the recognition<\/strong>\u00a0by <strong>industry experts<\/strong>\u00a0of <strong>META Pharmaceuticals\u2019 innovative ability<\/strong>\u00a0and <strong>development potential<\/strong>. <strong>META<\/strong>\u00a0will also <strong>accelerate the R&amp;D process<\/strong>, <strong>hoping to contribute<\/strong>\u00a0to the <strong>development of biomedicine<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, Shenzhen Moyuan Biotechnology Co., Ltd (herei [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/448"}],"collection":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/comments?post=448"}],"version-history":[{"count":1,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/448\/revisions"}],"predecessor-version":[{"id":460,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/448\/revisions\/460"}],"wp:attachment":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/media?parent=448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/categories?post=448"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/tags?post=448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}